Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Study status updated to Completed with an actual completion date of 2025-10-27, replacing the previous Active, not recruiting status. A list of trial locations across multiple US sites was added.
    Difference
    2%
    Check dated 2025-12-17T19:58:15.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 in the page footer, with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T08:00:59.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The government funding operating-status notice has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-19T08:38:44.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The screenshots show only minor UI/layout updates without any changes to core study content such as title, conditions, interventions, outcomes, eligibility criteria, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:15:15.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Update refresh: new operating-status notice and newer date/version metadata; removal of older last-update and disease-specific items.
    Difference
    4%
    Check dated 2025-10-06T16:07:55.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Updated terminology from Plasma cell myeloma to Multiple myeloma and bumped the revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-29T10:11:05.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.